TMCI · TREACE MEDICAL CONCEPTS, INC.
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Adductoplasty System, a system designed for the correction of metatarsus adductus deformities and osteoarthritis of the midfoot; SpeedMTP Rapid Compression Implant; SpeedPlate Implant Fixation Platform to address the fusion of larger bones of the midfoot and rearfoot; SpeedPlate Micro-Quad implant, an implant designed for stability and fit in small incision surgical approaches; and SpeedAkin Anatomic Compression Implant. In addition, the company offers The IntelliGuide patient specific instrumentation provides patient-specific, 3D-printed cut guides, and a pre-operative plan for a complete picture of the deformity and correction. Further, it provides FastGrafter Autografter Harvesting System; SpeedRelease Guided Release Instrument; TriTome Triple-Edge Release Instrument; RazorTome 7mm Precision Osteotome; LapiTome Hooked Bone Removal Osteotome; GreatRelease Rapid MTP Release Instrument; CornerChisel Release Tool; NanoRasp MIS Bone Contouring Tool; FeatherRasp Rapid Bone Contouring Instrument; and Akinator Single-cut Akin Wedge Osteotomy tool. Additionally, the company offers biologics and wedges, such as Treace Allograft Wedges; and CortiFuse Flowable Cortical Fibers. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
Cap structure and valuation
| Cap structure | |
|---|---|
| SP | $4.45 |
| SO | 64.9M |
| Options | 7.2M |
| Warrants | 0.0M |
| FD SO | 72.0M |
| MC | $320.5M |
| Cash | $9.5M |
| Total debt | $55.8M |
| EV | $366.8M |
| TTM Multiples | |
|---|---|
| EV / Revenue | 1.8x |
| EV / EBITDA | — |
| MC / Net Income | — |
| EV / FCF | — |
| MC / FCF | — |
| Ownership & coverage | |
|---|---|
| Institutional | 57.0% |
| Insiders | 25.3% |
| # Institutions | 165 |
| Analysts | 3 |
| Consensus | — |
| Avg target | $4.00 |
| Short % float | 3.4% |
| Days to cover | 1.46 |
MC = SP × FD SO. EV = MC + Debt − Cash. SP = previous yfinance close. Balance-sheet figures as of 2026-04-30. Multiples use TTM (sum of last 4 quarters); shown as "—" when the denominator is zero or negative, or when fewer than four quarters are reported — a partial sum is not a trailing twelve months. Ownership & coverage per Yahoo Finance as of 2026-07-13 — institutional % is 13F-based, so it can lag a quarter and exceed 100% on share-count timing. Short interest per FINRA bi-monthly reporting, as of 2026-06-29; the float denominator can be unreliable on tiny floats.
Financial statements
| 3/31/26 | 12/31/25 | 9/30/25 | 6/30/25 | |
|---|---|---|---|---|
| Total Revenue | 47.20 | 62.52 | 50.21 | 47.39 |
| Revenue YoY % | (10.2%) | (9.0%) | 11.4% | 6.6% |
| Cost of Revenue | 9.79 | 12.12 | 10.51 | 9.63 |
| Gross Profit | 37.41 | 50.40 | 39.71 | 37.75 |
| Gross Profit YoY % | (10.7%) | (9.1%) | 9.9% | 5.8% |
| Gross Margin % | 79.3% | 80.6% | 79.1% | 79.7% |
| SG&A | 49.95 | 51.78 | 50.70 | 49.23 |
| R&D | 4.62 | 4.54 | 4.68 | 5.50 |
| Operating Expense | 54.57 | 56.32 | 55.38 | 54.73 |
| Operating Income | (17.17) | (5.92) | (15.68) | (16.97) |
| Operating Income YoY % | (10.2%) | (2802.9%) | (3.6%) | 20.6% |
| Operating Margin % | (36.4%) | (9.5%) | (31.2%) | (35.8%) |
| EBITDA | (16.27) | (3.11) | (12.90) | (14.40) |
| EBITDA Margin % | (34.5%) | (5.0%) | (25.7%) | (30.4%) |
| Interest Expense | 1.57 | 1.35 | 1.34 | 1.32 |
| Other Income / (Expense) | 0.78 | (2.12) | 0.73 | 0.90 |
| Pretax Income | (17.96) | (9.39) | (16.29) | (17.40) |
| Tax Provision | — | 0.00 | — | — |
| Net Income | (17.96) | (9.39) | (16.29) | (17.40) |
| Net Margin % | (38.1%) | (15.0%) | (32.4%) | (36.7%) |
| Diluted EPS | -$0.28 | -$0.14 | -$0.26 | -$0.28 |
| Basic EPS | -$0.28 | -$0.14 | -$0.26 | -$0.28 |
| Diluted Avg Shares | 64.6 | — | 63.5 | 63.0 |
| Basic Avg Shares | 64.6 | — | 63.5 | 63.0 |
| LTM | 12/31/25 | 12/31/24 | 12/31/23 | 12/31/22 | |
|---|---|---|---|---|---|
| Total Revenue | 207.32 | 212.69 | 209.36 | 187.12 | 141.84 |
| Revenue YoY % | (2.5%) | 1.6% | 11.9% | 31.9% | — |
| Cost of Revenue | 42.05 | 42.94 | 41.09 | 35.18 | 25.53 |
| Gross Profit | 165.27 | 169.75 | 168.26 | 151.94 | 116.31 |
| Gross Profit YoY % | (2.6%) | 0.9% | 10.7% | 30.6% | — |
| Gross Margin % | 79.7% | 79.8% | 80.4% | 81.2% | 82.0% |
| SG&A | 201.66 | 203.62 | 203.36 | 187.93 | 137.57 |
| R&D | 19.34 | 20.28 | 20.59 | 15.44 | 13.58 |
| Operating Expense | 221.00 | 223.91 | 223.95 | 203.37 | 151.15 |
| Operating Income | (55.74) | (54.15) | (55.69) | (51.43) | (34.84) |
| Operating Income YoY % | (2.9%) | 2.8% | (8.3%) | (47.6%) | — |
| Operating Margin % | (26.9%) | (25.5%) | (26.6%) | (27.5%) | (24.6%) |
| EBITDA | (46.68) | (43.53) | (47.27) | (46.08) | (32.71) |
| EBITDA Margin % | (22.5%) | (20.5%) | (22.6%) | (24.6%) | (23.1%) |
| Interest Expense | 5.58 | 5.32 | 5.26 | 5.17 | 4.40 |
| Other Income / (Expense) | — | — | 5.20 | 7.07 | (3.57) |
| Pretax Income | (61.04) | (59.00) | (55.74) | (49.53) | (42.81) |
| Tax Provision | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | (61.04) | (59.00) | (55.74) | (49.53) | (42.81) |
| Net Income to Common | (61.04) | (59.00) | (55.74) | (50.00) | (43.00) |
| Net Margin % | (29.4%) | (27.7%) | (26.6%) | (26.5%) | (30.2%) |
| Diluted EPS | -$0.96 | -$0.93 | -$0.90 | -$0.81 | -$0.77 |
| Basic EPS | -$0.96 | -$0.93 | -$0.90 | -$0.81 | -$0.77 |
| Diluted Avg Shares | 64.6 | 63.3 | 62.1 | 60.9 | 55.3 |
| Basic Avg Shares | 64.6 | 63.3 | 62.1 | 60.9 | 55.3 |
| 3/31/26 | 12/31/25 | 9/30/25 | 6/30/25 | |
|---|---|---|---|---|
| Cash & Equivalents | 9.54 | 10.71 | 7.69 | 8.05 |
| Short-term Investments | 42.31 | 37.66 | 49.73 | 61.24 |
| Receivables | 30.36 | 42.16 | 32.96 | 30.33 |
| Inventory | 36.37 | 36.03 | 41.42 | 42.40 |
| Other Current Assets | 4.89 | 5.50 | 6.20 | 5.58 |
| Total Current Assets | 123.47 | 132.05 | 138.00 | 147.60 |
| Net PPE | 32.06 | 29.75 | 29.97 | 29.71 |
| Operating Lease ROU | 7.37 | 7.61 | 7.83 | 8.04 |
| Goodwill | 12.81 | 12.81 | 12.81 | 12.81 |
| Intangible Assets | 6.89 | 7.12 | 7.36 | 7.60 |
| Other Assets | 1.50 | 1.22 | — | — |
| Total Assets | 184.10 | 190.58 | 196.59 | 206.44 |
| Accounts Payable | 13.54 | 6.73 | 16.10 | 19.96 |
| Current Lease Liabilities | 0.46 | 0.55 | 2.12 | 2.09 |
| Other Current Liabilities | 20.50 | 23.36 | 22.69 | 19.85 |
| Total Current Liabilities | 34.49 | 30.64 | 40.91 | 41.90 |
| Long-term Debt | 55.82 | 55.58 | 53.53 | 53.45 |
| Long-term Lease Liabilities | 13.55 | 13.98 | 12.93 | 13.44 |
| Other Liabilities | 3.05 | 3.05 | — | — |
| Total Liabilities | 106.91 | 103.25 | 107.40 | 108.83 |
| Retained Earnings | (266.95) | (248.99) | (239.60) | (223.31) |
| Total Equity | 77.19 | 87.33 | 89.19 | 97.61 |
| LTM | 12/31/25 | 12/31/24 | 12/31/23 | 12/31/22 | |
|---|---|---|---|---|---|
| Cash & Equivalents | 9.54 | 10.71 | 11.35 | 12.98 | 19.47 |
| Short-term Investments | 42.31 | 37.66 | 64.33 | 110.22 | 61.78 |
| Receivables | 30.36 | 42.16 | 40.80 | 38.10 | 29.20 |
| Inventory | 36.37 | 36.03 | 39.26 | 29.25 | 19.33 |
| Other Current Assets | 4.89 | 5.50 | 5.67 | 7.82 | 3.62 |
| Total Current Assets | 123.47 | 132.05 | 161.40 | 198.36 | 133.40 |
| Net PPE | 32.06 | 29.75 | 25.95 | 22.30 | 15.34 |
| Operating Lease ROU | 7.37 | 7.61 | 8.44 | 9.26 | 10.14 |
| Goodwill | 12.81 | 12.81 | 12.81 | 12.81 | 0.00 |
| Intangible Assets | 6.89 | 7.12 | 8.07 | 9.03 | 0.00 |
| Other Assets | 1.50 | 1.22 | — | — | — |
| Total Assets | 184.10 | 190.58 | 217.09 | 251.91 | 159.02 |
| Accounts Payable | 13.54 | 6.73 | 10.52 | 11.84 | 8.67 |
| Current Lease Liabilities | 0.46 | 0.55 | 0.41 | 1.40 | 0.34 |
| Other Current Liabilities | 20.50 | 23.36 | 23.99 | 31.79 | 21.24 |
| Total Current Liabilities | 34.49 | 30.64 | 34.92 | 45.03 | 30.25 |
| Long-term Debt | 55.82 | 55.58 | 53.31 | 53.01 | 52.71 |
| Long-term Lease Liabilities | 13.55 | 13.98 | 15.93 | 15.89 | 15.54 |
| Other Liabilities | 3.05 | 3.05 | — | — | — |
| Total Liabilities | 106.91 | 103.25 | 104.20 | 113.97 | 98.50 |
| Retained Earnings | (266.95) | (248.99) | (189.99) | (134.25) | (84.72) |
| Total Equity | 77.19 | 87.33 | 112.89 | 137.94 | 60.53 |
| 3/31/26 | 12/31/25 | 9/30/25 | 6/30/25 | |
|---|---|---|---|---|
| Net Income | (17.96) | (9.39) | (16.29) | (17.40) |
| D&A | 0.90 | 2.81 | 2.78 | 2.58 |
| Stock-Based Comp | 8.03 | 7.55 | 8.00 | 9.58 |
| Δ Working Cap & Other | 16.27 | (8.99) | (3.58) | 2.19 |
| Operating Cash Flow | 7.24 | (8.03) | (9.09) | (3.05) |
| CapEx | (3.06) | (2.40) | (2.81) | (4.77) |
| Other Investing | (4.75) | 12.06 | 11.54 | 1.51 |
| Investing Cash Flow | (7.82) | 9.67 | 8.74 | (3.26) |
| Other Financing | (0.59) | 1.38 | — | 0.99 |
| Financing Cash Flow | (0.59) | 1.38 | (0.01) | 0.99 |
| Free Cash Flow | 4.18 | (10.42) | (11.90) | (7.82) |
| LTM | 12/31/25 | 12/31/24 | 12/31/23 | 12/31/22 | |
|---|---|---|---|---|---|
| Net Income | (61.04) | (59.00) | (55.74) | (49.53) | (42.81) |
| D&A | 9.06 | 10.62 | 8.42 | 5.35 | 2.13 |
| Stock-Based Comp | 33.16 | 33.82 | 30.60 | 17.35 | 8.11 |
| Δ Working Cap & Other | 5.89 | (1.41) | (20.45) | (7.75) | 1.92 |
| Operating Cash Flow | (12.93) | (15.97) | (37.17) | (34.58) | (30.65) |
| CapEx | (13.04) | (13.52) | (11.59) | (11.46) | (14.84) |
| Acquisitions | — | 0.00 | 0.00 | (20.00) | 0.00 |
| Other Investing | 20.36 | 26.77 | 46.97 | (49.84) | (61.68) |
| Investing Cash Flow | 7.33 | 13.25 | 35.38 | (81.30) | (76.52) |
| Debt Issuance | — | — | — | — | 0.00 |
| Debt Repayment | — | — | — | 0.00 | 0.00 |
| Other Financing | 1.77 | 2.08 | — | 109.38 | 20.81 |
| Financing Cash Flow | 1.77 | 2.08 | 0.16 | 109.38 | 20.81 |
| Free Cash Flow | (25.96) | (29.49) | (48.76) | (46.03) | (45.49) |
| 3/31/26 | 12/31/25 | 9/30/25 | 6/30/25 | |
|---|---|---|---|---|
| Current Ratio | 3.58 | 4.31 | 3.37 | 3.52 |
| Quick Ratio | 2.53 | 3.13 | 2.36 | 2.51 |
| Debt / Equity | 1.39 | 1.18 | 1.20 | 1.11 |
| EBITDA Margin % | (34.5%) | (5.0%) | (25.7%) | (30.4%) |
| Working Capital | 88.98 | 101.42 | 97.09 | 105.70 |
| Net Debt | 46.28 | 44.88 | 45.84 | 45.40 |
| ROE % | (23.3%) | (10.8%) | (18.3%) | (17.8%) |
| ROA % | (9.8%) | (4.9%) | (8.3%) | (8.4%) |
| LTM | 12/31/25 | 12/31/24 | 12/31/23 | 12/31/22 | |
|---|---|---|---|---|---|
| Current Ratio | 3.58 | 4.31 | 4.62 | 4.40 | 4.41 |
| Quick Ratio | 2.53 | 3.13 | 3.50 | 3.76 | 3.77 |
| Debt / Equity | 1.39 | 1.18 | 0.92 | 0.83 | 1.63 |
| EBITDA Margin % | (22.5%) | (20.5%) | (22.6%) | (24.6%) | (23.1%) |
| Working Capital | 88.98 | 101.42 | 126.48 | 153.33 | 103.16 |
| Net Debt | 46.28 | 44.88 | 41.96 | 40.03 | 33.24 |
| ROE % | (79.1%) | (67.6%) | (49.4%) | (35.9%) | (70.7%) |
| ROA % | (33.2%) | (31.0%) | (25.7%) | (19.7%) | (26.9%) |
Insider activity (last 2 years)
| Date Filed | Reporter | Relationship | Trans. Date | Code | Shares | Price | Total Value |
|---|---|---|---|---|---|---|---|
| 2026-06-12 | Treace John T. | Director, Officer (Chief Executive Officer), 10% Owner | 2026-06-11 | P | 9,891 | $4.04 | $39,982 |
| 2026-06-12 | Treace John T. | Director, Officer (Chief Executive Officer), 10% Owner | 2026-06-10 | P | 14,715 | $4.02 | $59,213 |
| 2026-06-11 | Treace John T. | Director, Officer (Chief Executive Officer), 10% Owner | 2026-06-11 | P | 22,887 | $4.04 | $92,541 |
| 2026-06-11 | Treace John T. | Director, Officer (Chief Executive Officer), 10% Owner | 2026-06-10 | P | 29,430 | $4.02 | $118,426 |
| 2026-06-01 | Treace John T. | Director, Officer (Chief Executive Officer), 10% Owner | 2026-06-01 | P | 50,000 | $3.56 | $177,915 |
| 2026-05-28 | Treace John T. | Director, Officer (Chief Executive Officer), 10% Owner | 2026-05-28 | P | 61,202 | $3.02 | $184,824 |
| 2026-05-28 | Treace John T. | Director, Officer (Chief Executive Officer), 10% Owner | 2026-05-27 | P | 49,810 | $2.87 | $143,189 |
| 2026-05-28 | Treace John T. | Director, Officer (Chief Executive Officer), 10% Owner | 2026-05-26 | P | 4,508 | $2.79 | $12,576 |
| 2026-05-19 | BAKEWELL JOHN K | Director | 2026-05-19 | A | 30,000 | — | $0 |
| 2026-05-19 | Kiernan Jane E | Director | 2026-05-19 | A | 30,000 | — | $0 |
| 2026-05-19 | Berry Lance A | Director | 2026-05-19 | A | 30,000 | — | $0 |
| 2026-05-19 | Jain Deepti | Director | 2026-05-19 | A | 30,000 | — | $0 |
| 2026-05-19 | HAMILTON LAWRENCE W | Director | 2026-05-19 | A | 30,000 | — | $0 |
| 2026-05-19 | Hanna Betsy | Director | 2026-05-19 | A | 30,000 | — | $0 |
| 2026-05-14 | Treace John T. | Director, Officer (Chief Executive Officer), 10% Owner | 2026-05-14 | P | 61,750 | $2.62 | $161,495 |
| 2026-05-14 | Treace John T. | Director, Officer (Chief Executive Officer), 10% Owner | 2026-05-13 | P | 49,013 | $2.46 | $120,533 |
| 2026-05-14 | Treace John T. | Director, Officer (Chief Executive Officer), 10% Owner | 2026-05-12 | P | 43,000 | $2.17 | $93,478 |
| 2026-04-20 | Hair Mark | Officer (Chief Financial Officer) | 2026-04-17 | F | (11,547) | — | $-0 |
| 2026-04-03 | Hair Mark | Officer (Chief Financial Officer) | 2026-04-01 | A | 100,000 | — | $0 |
| 2026-03-11 | Elder Scot Michael | Officer (Chief Legl & Comp Off, CorpSec) | 2026-03-10 | F | (1,675) | — | $-0 |
| 2026-03-11 | Scanlan Sean F. | Officer (Chief Innovation Officer) | 2026-03-10 | F | (1,396) | — | $-0 |
| 2026-03-11 | Treace John T. | Director, Officer (Chief Executive Officer), 10% Owner | 2026-03-10 | F | (5,021) | — | $-0 |
| 2026-03-11 | Hair Mark | Officer (Chief Financial Officer) | 2026-03-10 | F | (3,695) | — | $-0 |
| 2026-03-11 | Elder Scot Michael | Officer (Chief Legl & Comp Off, CorpSec) | 2026-03-08 | F | (175) | — | $-0 |
| 2026-03-11 | Scanlan Sean F. | Officer (Chief Innovation Officer) | 2026-03-08 | F | (401) | — | $-0 |
| 2026-03-11 | Treace John T. | Director, Officer (Chief Executive Officer), 10% Owner | 2026-03-08 | F | (2,062) | — | $-0 |
| 2026-03-11 | Hair Mark | Officer (Chief Financial Officer) | 2026-03-08 | F | (964) | — | $-0 |
| 2026-02-11 | Scanlan Sean F. | Officer (Chief Innovation Officer) | 2026-02-10 | M | 16,875 | $1.05 | $17,719 |
| 2026-02-11 | Scanlan Sean F. | Officer (Chief Innovation Officer) | 2026-02-10 | M | (16,875) | — | $-0 |
| 2026-01-23 | Guglielmino Gaetano | Officer (Chief Commercial Officer) | 2026-01-22 | A | 150,000 | — | $0 |
| 2026-01-23 | Elder Scot Michael | Officer (Chief Legl & Comp Off, CorpSec) | 2026-01-22 | F | (9,451) | — | $-0 |
| 2026-01-23 | Elder Scot Michael | Officer (Chief Legl & Comp Off, CorpSec) | 2026-01-22 | A | 262,500 | — | $0 |
| 2026-01-23 | Hair Mark | Officer (Chief Financial Officer) | 2026-01-22 | F | (17,037) | — | $-0 |
| 2026-01-23 | Hair Mark | Officer (Chief Financial Officer) | 2026-01-22 | A | 375,000 | — | $0 |
| 2026-01-23 | Scanlan Sean F. | Officer (Chief Innovation Officer) | 2026-01-22 | A | 262,500 | — | $0 |
| 2026-01-23 | Treace John T. | Director, Officer (Chief Executive Officer), 10% Owner | 2026-01-22 | F | (14,254) | — | $-0 |
| 2026-01-23 | Treace John T. | Director, Officer (Chief Executive Officer), 10% Owner | 2026-01-22 | A | 250,000 | — | $0 |
| 2026-01-23 | Scanlan Sean F. | Officer (Chief Innovation Officer) | 2026-01-21 | M | 53,500 | $0.72 | $38,520 |
| 2026-01-23 | Scanlan Sean F. | Officer (Chief Innovation Officer) | 2026-01-21 | M | 53,500 | — | $0 |
| 2026-01-13 | Hair Mark | Officer (Chief Financial Officer) | 2026-01-10 | F | (8,719) | — | $-0 |
| 2026-01-13 | Elder Scot Michael | Officer (Chief Legl & Comp Off, CorpSec) | 2026-01-10 | F | (4,544) | — | $-0 |
| 2026-01-13 | Treace John T. | Director, Officer (Chief Executive Officer), 10% Owner | 2026-01-10 | F | (13,219) | — | $-0 |
| 2025-12-03 | Guglielmino Guy | Officer (Chief Commercial Officer) | 2025-12-01 | F | (20,090) | — | $-0 |
| 2025-12-03 | Guglielmino Guy | Officer (Chief Commercial Officer) | 2025-12-01 | F | (2,009) | — | $-0 |
| 2025-10-28 | Elder Scot Michael | Officer (Chief Legl & Comp Off, CorpSec) | 2025-10-25 | F | (984) | — | $-0 |
| 2025-10-28 | Scanlan Sean F. | Officer (Chief Innovation Officer) | 2025-10-24 | F | (208) | — | $-0 |
| 2025-10-02 | Elder Scot Michael | Officer (Chief Legl & Comp Off, CorpSec) | 2025-10-02 | F | (650) | — | $-0 |
| 2025-10-02 | Elder Scot Michael | Officer (Chief Legl & Comp Off, CorpSec) | 2025-09-30 | F | (16,234) | — | $-0 |
| 2025-08-12 | Elder Scot Michael | Officer (Chief Legl & Comp Off, CorpSec) | 2025-08-09 | F | (10,515) | — | $-0 |
| 2025-08-12 | Hair Mark | Officer (Chief Financial Officer) | 2025-08-09 | F | (22,212) | — | $-0 |
| 2025-08-12 | Scanlan Sean F. | Officer (Chief Innovation Officer) | 2025-08-09 | F | (9,814) | — | $-0 |
| 2025-08-12 | Berutti Aaron | Officer (SVP, Sales) | 2025-08-09 | F | (4,907) | — | $-0 |
| 2025-07-22 | Scanlan Sean F. | Officer (Chief Innovation Officer) | 2025-07-18 | M | 33,437 | $0.72 | $24,001 |
| 2025-07-22 | Scanlan Sean F. | Officer (Chief Innovation Officer) | 2025-07-18 | M | (33,437) | — | $-0 |
| 2025-05-21 | Jain Deepti | Director | 2025-05-20 | A | 23,917 | — | $0 |
| 2025-05-21 | Berry Lance A | Director | 2025-05-20 | A | 23,917 | — | $0 |
| 2025-05-21 | HAMILTON LAWRENCE W | Director | 2025-05-20 | A | 23,917 | — | $0 |
| 2025-05-21 | Kiernan Jane E | Director | 2025-05-20 | A | 23,917 | — | $0 |
| 2025-05-21 | Hanna Betsy | Director | 2025-05-20 | A | 23,917 | — | $0 |
| 2025-05-21 | MOTT RICHARD W | Director | 2025-05-20 | A | 23,917 | — | $0 |
| 2025-05-21 | BAKEWELL JOHN K | Director | 2025-05-20 | A | 23,917 | — | $0 |
| 2025-05-12 | Elder Scot Michael | Officer (Chief Legl & Comp Off, CorpSec) | 2025-05-08 | A | 7,775 | — | $0 |
| 2025-05-12 | Elder Scot Michael | Officer (Chief Legl & Comp Off, CorpSec) | 2025-05-08 | F | (1,894) | $7.54 | -$14,281 |
| 2025-03-19 | Scanlan Sean F. | Officer (Chief Innovation Officer) | 2025-03-17 | M | 50,000 | $1.05 | $52,500 |
| 2025-03-19 | Scanlan Sean F. | Officer (Chief Innovation Officer) | 2025-03-17 | S | (50,000) | $7.97 | -$398,460 |
| 2025-03-19 | Scanlan Sean F. | Officer (Chief Innovation Officer) | 2025-03-17 | M | (50,000) | — | $-0 |
| 2025-03-11 | Berutti Aaron | Officer (SVP, Sales) | 2025-03-10 | F | (1,815) | — | $-0 |
| 2025-03-11 | Treace John T. | Director, Officer (Chief Executive Officer), 10% Owner | 2025-03-10 | F | (5,021) | — | $-0 |
| 2025-03-11 | Scanlan Sean F. | Officer (Chief Innovation Officer) | 2025-03-10 | F | (1,396) | — | $-0 |
| 2025-03-11 | Elder Scot Michael | Officer (Chief Legl & Comp Off, CorpSec) | 2025-03-10 | F | (1,675) | — | $-0 |
| 2025-03-11 | Hair Mark | Officer (Chief Financial Officer) | 2025-03-10 | F | (3,684) | — | $-0 |
| 2025-03-11 | Berutti Aaron | Officer (SVP, Sales) | 2025-03-08 | F | (728) | — | $-0 |
| 2025-03-11 | Treace John T. | Director, Officer (Chief Executive Officer), 10% Owner | 2025-03-08 | F | (2,063) | — | $-0 |
| 2025-03-11 | Scanlan Sean F. | Officer (Chief Innovation Officer) | 2025-03-08 | F | (401) | — | $-0 |
| 2025-03-11 | Elder Scot Michael | Officer (Chief Legl & Comp Off, CorpSec) | 2025-03-08 | F | (176) | — | $-0 |
| 2025-03-11 | Hair Mark | Officer (Chief Financial Officer) | 2025-03-08 | F | (961) | — | $-0 |
| 2025-03-04 | Treace John T. | Director, Officer (Chief Executive Officer), 10% Owner | 2025-03-04 | P | 60,000 | $8.73 | $524,064 |
| 2025-01-24 | Berutti Aaron | Officer (SVP, Sales) | 2025-01-22 | A | 75,000 | — | $0 |
| 2025-01-24 | Scanlan Sean F. | Officer (Chief Innovation Officer) | 2025-01-22 | A | 140,625 | — | $0 |
| 2025-01-24 | Elder Scot Michael | Officer (Chief Legl & Comp Off, CorpSec) | 2025-01-22 | A | 127,500 | — | $0 |
| 2025-01-24 | Treace John T. | Director, Officer (Chief Executive Officer), 10% Owner | 2025-01-22 | A | 225,000 | — | $0 |
| 2025-01-24 | Hair Mark | Officer (Chief Financial Officer) | 2025-01-22 | A | 187,500 | — | $0 |
| 2025-01-14 | Hair Mark | Officer (Chief Financial Officer) | 2025-01-10 | F | (8,594) | — | $-0 |
| 2025-01-14 | Scanlan Sean F. | Officer (Chief Innovation Officer) | 2025-01-10 | F | (4,821) | — | $-0 |
| 2025-01-14 | Elder Scot Michael | Officer (Chief Legl & Comp Off, CorpSec) | 2025-01-10 | F | (4,544) | — | $-0 |
| 2025-01-14 | Berutti Aaron | Officer (SVP, Sales) | 2025-01-10 | F | (4,821) | — | $-0 |
| 2025-01-14 | Treace John T. | Director, Officer (Chief Executive Officer), 10% Owner | 2025-01-10 | F | (11,905) | — | $-0 |
| 2024-12-05 | Guglielmino Guy | Officer (Chief Commercial Officer) | 2024-12-01 | A | 330,000 | — | $0 |
| 2024-12-05 | Guglielmino Guy | Officer (Chief Commercial Officer) | 2024-12-01 | A | 33,000 | — | $0 |
| 2024-11-13 | Elder Scot Michael | Officer (Chief Legl & Comp Off, CorpSec) | 2024-11-11 | A | 15,550 | — | $0 |
| 2024-11-13 | Elder Scot Michael | Officer (Chief Legl & Comp Off, CorpSec) | 2024-11-11 | F | (3,787) | $8.29 | -$31,394 |
| 2024-10-02 | Elder Scot Michael | Officer (Chief Legl & Comp Off, CorpSec) | 2024-09-30 | A | 200,000 | — | $0 |
| 2024-09-17 | Treace John T. | Director, Officer (Chief Executive Officer), 10% Owner | 2024-09-16 | P | 50,000 | $5.31 | $265,630 |
| 2024-09-16 | Scanlan Sean F. | Officer (Chief Innovation Officer) | 2024-09-12 | M | 33,750 | $0.10 | $3,280 |
| 2024-09-16 | Scanlan Sean F. | Officer (Chief Innovation Officer) | 2024-09-12 | M | (33,750) | — | $-0 |
| 2024-08-19 | TREACE JAMES T | Director | 2024-08-15 | P | 84,000 | $5.96 | $501,035 |
| 2024-08-15 | Treace John T. | Director, Officer (Chief Executive Officer), 10% Owner | 2024-08-14 | P | 85,000 | $6.00 | $510,314 |
| 2024-08-09 | Berutti Aaron | Officer (SVP, Sales) | 2024-08-09 | A | 60,450 | — | $0 |
| 2024-08-09 | Scanlan Sean F. | Officer (Chief Innovation Officer) | 2024-08-09 | A | 120,900 | — | $0 |
| 2024-08-09 | Hair Mark | Officer (Chief Financial Officer) | 2024-08-09 | A | 207,260 | — | $0 |
| 2024-08-09 | Elder Scot Michael | Officer (Chief Legl & Comp Off, CorpSec) | 2024-08-09 | A | 129,540 | — | $0 |